March’s top stories: Baxter to split, first migraine device gets FDA clearance
Baxter revealed its plans to split itself into two separate and independent entities, while Cefaly Technology obtained FDA clearance…
By
Paladugu Rajesh Kumar
All Articles
February’s top stories: Thermo Fisher’s $13.6bn deal, Medtronic’s leadless pacemaker
Thermo Fisher Scientific completed its acquisition of Life Technologies, a life sciences company, for approximately $13.6bn, while Medtronic reported…
By
January’s top stories: Carlyle’s $4.15bn acquistion, Edwards Lifesciences’ approval
The Carlyle Group agreed to buy Johnson & Johnson's Ortho-Clinical Diagnostics (OCD) business for $4.15bn, while Edwards Lifesciences obtained…
By